These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38164231)
21. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. King KS; Chen CC; Alexopoulos DK; Whatley MA; Reynolds JC; Patronas N; Ling A; Adams KT; Xekouki P; Lando H; Stratakis CA; Pacak K J Clin Endocrinol Metab; 2011 Sep; 96(9):2779-85. PubMed ID: 21752889 [TBL] [Abstract][Full Text] [Related]
22. Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT. Fikri AS; Kroiss A; Ahmad AZ; Zanariah H; Lau WF; Uprimny C; Donnemiller E; Kendler D; Nordin AJ; Virgolini IJ Acta Radiol; 2014 Jun; 55(5):631-40. PubMed ID: 24037430 [TBL] [Abstract][Full Text] [Related]
23. Predictive value of dual-time Pahk K; Chung JH; Kim S; Lee SH Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664 [TBL] [Abstract][Full Text] [Related]
24. Succinate Dehydrogenase B Subunit-Negative Jugular Foramen Paraganglioma Manifesting Malignant Progression with Pseudohypoxia-Related Atypical Uptake of [ Ohtake M; Tateishi K; Murata H; Nagashima Y; Yamanaka S; Yamamoto T World Neurosurg; 2018 Jun; 114():47-52. PubMed ID: 29510284 [TBL] [Abstract][Full Text] [Related]
25. Clinical, Diagnostic, and Treatment Characteristics of Jha A; de Luna K; Balili CA; Millo C; Paraiso CA; Ling A; Gonzales MK; Viana B; Alrezk R; Adams KT; Tena I; Chen A; Neuzil J; Raygada M; Kebebew E; Taieb D; O'Dorisio MS; O'Dorisio T; Civelek AC; Stratakis CA; Mercado-Asis L; Pacak K Front Oncol; 2019; 9():53. PubMed ID: 30854332 [No Abstract] [Full Text] [Related]
26. Xie X; Tu N; Wang Q; Cheng Z; Han X; Bu L Thorac Cancer; 2020 Aug; 11(8):2325-2330. PubMed ID: 32410331 [TBL] [Abstract][Full Text] [Related]
27. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by van Berkel A; Vriens D; Visser EP; Janssen MJR; Gotthardt M; Hermus ARMM; Geus-Oei LF; Timmers HJLM J Nucl Med; 2019 Jun; 60(6):745-751. PubMed ID: 30413658 [TBL] [Abstract][Full Text] [Related]
28. Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up. Lepoutre-Lussey C; Caramella C; Bidault F; Déandreis D; Berdelou A; Al Ghuzlan A; Hartl D; Borget I; Gimenez-Roqueplo AP; Dumont F; Deschamps F; Nascimento C; Lumbroso J; Guillaud Bataille M; Schlumberger M; Baudin E; Leboulleux S Eur J Nucl Med Mol Imaging; 2015 May; 42(6):868-76. PubMed ID: 25676472 [TBL] [Abstract][Full Text] [Related]
29. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma. Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216 [TBL] [Abstract][Full Text] [Related]
30. A case report of primary pulmonary meningioma masquerading as lung metastasis in a patient with rectal carcinoma: role of Jiang M; Chen P; Huang R; Zhang J; Zheng J J Cardiothorac Surg; 2021 May; 16(1):153. PubMed ID: 34051819 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the Sensitivity of Dodamani MH; Jaiswal SK; Sarathi V; Marfatia H; D'Cruz A; Malhotra G; Hira P; Patil VA; Lila AR; Shah NS; Bandgar TR World J Nucl Med; 2022 Sep; 21(3):184-191. PubMed ID: 36060084 [No Abstract] [Full Text] [Related]
32. First Experience Using Kessler L; Schlitter AM; Krönke M; von Werder A; Tauber R; Maurer T; Robinson S; Orlandi C; Herz M; Yousefi BH; Nekolla SG; Schwaiger M; Eiber M; Rischpler C J Nucl Med; 2021 Apr; 62(4):479-485. PubMed ID: 32859709 [TBL] [Abstract][Full Text] [Related]
33. Clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors. Nishii R; Saga T; Sudo H; Togawa T; Kuyama J; Tani T; Maeda T; Kobayashi M; Iizasa T; Shingyoji M; Itami M; Kawamura K; Hashimoto H; Yamazaki K; Tamura K; Higashi T Ann Nucl Med; 2021 Feb; 35(2):211-222. PubMed ID: 33387282 [TBL] [Abstract][Full Text] [Related]
34. MRI, enhanced CT, and FDG PET/CT in primary retroperitoneal mucinous cystadenocarcinoma. Dong A; Zhai Z; Wang Y; Zuo C Clin Nucl Med; 2015 Jan; 40(1):50-3. PubMed ID: 24445275 [TBL] [Abstract][Full Text] [Related]
36. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer. Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091 [TBL] [Abstract][Full Text] [Related]
37. 18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study. Blanchet EM; Taieb D; Millo C; Martucci V; Chen CC; Merino M; Herscovitch P; Pacak K J Nucl Med; 2015 Dec; 56(12):1849-54. PubMed ID: 26359261 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies. Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Umutlu L; Antoch G; Heusch P J Nucl Med; 2016 Jan; 57(1):15-20. PubMed ID: 26514173 [TBL] [Abstract][Full Text] [Related]
39. Transformation of a Nonfunctional Paraganglioma With I-123 MIBG Scintigraphy Correlation: A Case Report. Davalos EA; Cho J; Dave H; Shen H; Barank D; Shim J Medicine (Baltimore); 2016 Jan; 95(2):e2501. PubMed ID: 26765464 [TBL] [Abstract][Full Text] [Related]